Ryanair Gains on Narrower Net Loss; Regeneron Melanoma Trial Failure | Stock Movers
BloombergDuration: 3:10
Read the full storyUp next
- Monte Paschi CEO Says Shareholders Will See Value in Twin Offers
- Goldman Sachs: Euro Stocks Resilient to Macro Pressures
- French Inflation Accelerates to Highest in Two Years
- US Dollar to Gain From Capital Flows: Market Analysis
- RBC Says 30-Year Treasury Yield at 6% Is Possible
- How Abu Dhabi's Crown Prince Is Trying to Bypass Hormuz
